US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 2.9200
  • -0.0300-1.02%
Close Nov 29 13:00 ET
  • 2.9200
  • 0.00000.00%
Post 17:01 ET
26.95MMarket Cap-463P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.75%-6.29M
-57.53%-7.72M
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
-1,280.73%-23.46M
68.12%-1.56M
Net income from continuing operations
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
-125.14%-42.19M
-190.26%-22.86M
27.89%-5.1M
-44.07%-6.88M
-845.93%-7.35M
-9.31%-18.74M
31.83%-7.87M
Operating gains losses
96.84%-6.17K
-720.10%-2.22M
-6,521.24%-5.47M
146.74%4.87M
13,183.43%4.79M
75.08%-195.47K
120.66%357.52K
98.95%-82.59K
-399.28%-10.42M
-100.88%-36.6K
Depreciation and amortization
-1.89%966.86K
18.27%1.06M
114.99%1.98M
13.77%3.75M
2.26%944.4K
8.30%985.45K
14.25%892.27K
36.27%923.17K
99.07%3.29M
39.68%923.52K
Other non cash items
---48.36K
-270.80%-85.4K
-189.80%-83.99K
11,623.32%3.71M
--3.57M
--0
--50K
--93.53K
---32.21K
----
Change In working capital
240.24%2.1M
609.17%263.34K
-165.88%-2.77M
1,079.15%2.33M
-108.84%-427.41K
3.33%-1.49M
-94.75%37.13K
199.44%4.21M
-102.03%-237.58K
299.83%4.84M
-Change in receivables
-64.65%127.88K
-107.90%-31.69K
-104.03%-193.23K
126.42%5.56M
--0
110.86%361.74K
-81.53%401.39K
226.95%4.79M
-80.46%2.45M
235.32%7.39M
-Change in prepaid assets
-111.21%-25.84K
103.06%687.93K
-190.79%-289.54K
-177.62%-523.61K
-155.56%-1.41M
-74.44%230.56K
-50.14%338.79K
189.93%318.9K
153.61%674.55K
65.25%-552.46K
-Change in payables and accrued expense
309.99%1.99M
86.03%-111.71K
66.30%-1.34M
-33.04%-4.42M
161.02%1.3M
-203.00%-947.76K
62.41%-799.85K
-29,207.33%-3.97M
-843.79%-3.32M
-445.79%-2.13M
-Change in other current assets
-96.89%3.99K
-112.79%-18.06K
-108.29%-10.4K
624.72%387.3K
-105.88%-7.56K
426.64%128.11K
885.63%141.22K
794.31%125.53K
183.99%53.44K
828.78%128.72K
-Change in other working capital
--0
-492.42%-263.14K
-132.14%-944.58K
1,422.41%1.32M
---305.01K
---1.27M
---44.42K
3,039.20%2.94M
---100K
--0
Cash from discontinued investing activities
Operating cash flow
-21.75%-6.29M
-57.53%-7.72M
-569.48%-10.75M
-7.08%-25.12M
-764.73%-13.45M
34.74%-5.17M
-10.14%-4.9M
83.16%-1.61M
-1,280.73%-23.46M
68.12%-1.56M
Investing cash flow
Cash flow from continuing investing activities
-2,721.23%-1.15M
49,556.96%11.22M
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
Net PPE purchase and sale
-145.50%-100.3K
-131.49%-52.51K
-505.98%-129.07K
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
Net investment purchase and sale
---1.05M
--11.27M
---31.23M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-2,721.23%-1.15M
49,556.96%11.22M
-147,126.32%-31.36M
92.69%-152.7K
42.37%-67.86K
47.96%-40.86K
96.30%-22.68K
98.34%-21.3K
80.90%-2.09M
95.01%-117.75K
Financing cash flow
Cash flow from continuing financing activities
-380.46%-674.13K
11.75%-321.04K
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
-97.07%1.05M
-76.72%8.39M
Net issuance payments of debt
-354.77%-649.13K
30.64%-252.33K
31.59%-247.44K
67.05%-390.45K
-32.39%477.76K
50.28%-142.74K
54.54%-363.79K
55.04%-361.68K
-176.73%-1.19M
-58.12%706.69K
Net common stock issuance
----
----
----
--0
----
----
----
----
--2.16M
--7.68M
Net preferred stock issuance
----
----
----
--7.5M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--0
--0
980.00%20.41K
77,414.37%59.66M
5,965,926,300.00%59.66M
242,900.00%2.43K
--0
-75.86%1.89K
1,040.31%76.97K
-100.01%-1
Net other financing activities
---25K
---68.71K
---167.39K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-380.46%-674.13K
11.75%-321.04K
-9.62%-394.42K
6,250.81%66.77M
706.40%67.64M
51.13%-140.31K
50.24%-363.79K
94.31%-359.79K
-97.07%1.05M
-76.72%8.39M
Net cash flow
Beginning cash position
121.78%17.24M
7.46%14.03M
275.93%56.57M
-61.95%15.05M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
-61.95%15.05M
213.59%39.55M
-22.50%8.33M
Current changes in cash
-51.78%-8.12M
160.16%3.18M
-2,039.29%-42.5M
269.40%41.5M
706.03%54.12M
35.43%-5.35M
8.74%-5.29M
88.41%-1.99M
-190.95%-24.5M
-76.68%6.71M
Effect of exchange rate changes
--47.54K
--28.28K
---28.27K
--18.14K
--18.14K
--0
--0
--0
--0
----
End cash Position
278.12%9.17M
121.78%17.24M
7.46%14.03M
275.93%56.57M
275.93%56.57M
-70.89%2.43M
-53.21%7.77M
-41.72%13.06M
-61.95%15.05M
-61.95%15.05M
Free cash flow
-21.69%-6.39M
-57.87%-7.77M
-568.65%-10.88M
1.21%-25.32M
-707.91%-13.51M
34.31%-5.25M
2.75%-4.92M
85.07%-1.63M
-186.11%-25.63M
76.90%-1.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.75%-6.29M -57.53%-7.72M -569.48%-10.75M -7.08%-25.12M -764.73%-13.45M 34.74%-5.17M -10.14%-4.9M 83.16%-1.61M -1,280.73%-23.46M 68.12%-1.56M
Net income from continuing operations -102.84%-10.35M -6.61%-7.34M 31.66%-5.03M -125.14%-42.19M -190.26%-22.86M 27.89%-5.1M -44.07%-6.88M -845.93%-7.35M -9.31%-18.74M 31.83%-7.87M
Operating gains losses 96.84%-6.17K -720.10%-2.22M -6,521.24%-5.47M 146.74%4.87M 13,183.43%4.79M 75.08%-195.47K 120.66%357.52K 98.95%-82.59K -399.28%-10.42M -100.88%-36.6K
Depreciation and amortization -1.89%966.86K 18.27%1.06M 114.99%1.98M 13.77%3.75M 2.26%944.4K 8.30%985.45K 14.25%892.27K 36.27%923.17K 99.07%3.29M 39.68%923.52K
Other non cash items ---48.36K -270.80%-85.4K -189.80%-83.99K 11,623.32%3.71M --3.57M --0 --50K --93.53K ---32.21K ----
Change In working capital 240.24%2.1M 609.17%263.34K -165.88%-2.77M 1,079.15%2.33M -108.84%-427.41K 3.33%-1.49M -94.75%37.13K 199.44%4.21M -102.03%-237.58K 299.83%4.84M
-Change in receivables -64.65%127.88K -107.90%-31.69K -104.03%-193.23K 126.42%5.56M --0 110.86%361.74K -81.53%401.39K 226.95%4.79M -80.46%2.45M 235.32%7.39M
-Change in prepaid assets -111.21%-25.84K 103.06%687.93K -190.79%-289.54K -177.62%-523.61K -155.56%-1.41M -74.44%230.56K -50.14%338.79K 189.93%318.9K 153.61%674.55K 65.25%-552.46K
-Change in payables and accrued expense 309.99%1.99M 86.03%-111.71K 66.30%-1.34M -33.04%-4.42M 161.02%1.3M -203.00%-947.76K 62.41%-799.85K -29,207.33%-3.97M -843.79%-3.32M -445.79%-2.13M
-Change in other current assets -96.89%3.99K -112.79%-18.06K -108.29%-10.4K 624.72%387.3K -105.88%-7.56K 426.64%128.11K 885.63%141.22K 794.31%125.53K 183.99%53.44K 828.78%128.72K
-Change in other working capital --0 -492.42%-263.14K -132.14%-944.58K 1,422.41%1.32M ---305.01K ---1.27M ---44.42K 3,039.20%2.94M ---100K --0
Cash from discontinued investing activities
Operating cash flow -21.75%-6.29M -57.53%-7.72M -569.48%-10.75M -7.08%-25.12M -764.73%-13.45M 34.74%-5.17M -10.14%-4.9M 83.16%-1.61M -1,280.73%-23.46M 68.12%-1.56M
Investing cash flow
Cash flow from continuing investing activities -2,721.23%-1.15M 49,556.96%11.22M -147,126.32%-31.36M 92.69%-152.7K 42.37%-67.86K 47.96%-40.86K 96.30%-22.68K 98.34%-21.3K 80.90%-2.09M 95.01%-117.75K
Net PPE purchase and sale -145.50%-100.3K -131.49%-52.51K -505.98%-129.07K 92.69%-152.7K 42.37%-67.86K 47.96%-40.86K 96.30%-22.68K 98.34%-21.3K 80.90%-2.09M 95.01%-117.75K
Net investment purchase and sale ---1.05M --11.27M ---31.23M ---- ---- --0 --0 --0 ---- ----
Cash from discontinued investing activities
Investing cash flow -2,721.23%-1.15M 49,556.96%11.22M -147,126.32%-31.36M 92.69%-152.7K 42.37%-67.86K 47.96%-40.86K 96.30%-22.68K 98.34%-21.3K 80.90%-2.09M 95.01%-117.75K
Financing cash flow
Cash flow from continuing financing activities -380.46%-674.13K 11.75%-321.04K -9.62%-394.42K 6,250.81%66.77M 706.40%67.64M 51.13%-140.31K 50.24%-363.79K 94.31%-359.79K -97.07%1.05M -76.72%8.39M
Net issuance payments of debt -354.77%-649.13K 30.64%-252.33K 31.59%-247.44K 67.05%-390.45K -32.39%477.76K 50.28%-142.74K 54.54%-363.79K 55.04%-361.68K -176.73%-1.19M -58.12%706.69K
Net common stock issuance ---- ---- ---- --0 ---- ---- ---- ---- --2.16M --7.68M
Net preferred stock issuance ---- ---- ---- --7.5M ---- ---- ---- ---- --0 ----
Proceeds from stock option exercised by employees --0 --0 980.00%20.41K 77,414.37%59.66M 5,965,926,300.00%59.66M 242,900.00%2.43K --0 -75.86%1.89K 1,040.31%76.97K -100.01%-1
Net other financing activities ---25K ---68.71K ---167.39K ---- ---- ---- ---- ---- ---- ----
Cash from discontinued financing activities
Financing cash flow -380.46%-674.13K 11.75%-321.04K -9.62%-394.42K 6,250.81%66.77M 706.40%67.64M 51.13%-140.31K 50.24%-363.79K 94.31%-359.79K -97.07%1.05M -76.72%8.39M
Net cash flow
Beginning cash position 121.78%17.24M 7.46%14.03M 275.93%56.57M -61.95%15.05M -70.89%2.43M -53.21%7.77M -41.72%13.06M -61.95%15.05M 213.59%39.55M -22.50%8.33M
Current changes in cash -51.78%-8.12M 160.16%3.18M -2,039.29%-42.5M 269.40%41.5M 706.03%54.12M 35.43%-5.35M 8.74%-5.29M 88.41%-1.99M -190.95%-24.5M -76.68%6.71M
Effect of exchange rate changes --47.54K --28.28K ---28.27K --18.14K --18.14K --0 --0 --0 --0 ----
End cash Position 278.12%9.17M 121.78%17.24M 7.46%14.03M 275.93%56.57M 275.93%56.57M -70.89%2.43M -53.21%7.77M -41.72%13.06M -61.95%15.05M -61.95%15.05M
Free cash flow -21.69%-6.39M -57.87%-7.77M -568.65%-10.88M 1.21%-25.32M -707.91%-13.51M 34.31%-5.25M 2.75%-4.92M 85.07%-1.63M -186.11%-25.63M 76.90%-1.67M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data